Cancer Genetics, Inc. CGIX
$ 4.61
-2.33%
Cancer Genetics, Inc. Balance Sheet 2011-2024 | CGIX
Annual Balance Sheet Cancer Genetics, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-2.22 M | - | - | - | - | - | - | - | - | - |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
4.26 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
4.37 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
1.01 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | - | - | - | - | - | - |
Total Assets |
8.35 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency